US 12,454,546 B2
Inotodiol ester derivative precursor drug
Jongtae Park, Daejeon (KR); Phu Cuong Nguyen, Daejeon (KR); Kyubeen Park, Sejong (KR); and Nan Young Lee, Daejeon (KR)
Assigned to CARBOEXPERT INC., Daejeon (KR); and THE INUDSTRY & ACADEMIC COOPERATION IN CHUNGNAM NATIONAL UNIVERSITY, Daejeon (KR)
Appl. No. 18/019,875
Filed by CARBOEXPERT INC., Daejeon (KR); and THE INDUSTRY & ACADEMIC COOPERATION IN CHUNGNAM NATIONAL UNIVERSITY (IAC), Daejeon (KR)
PCT Filed Aug. 6, 2021, PCT No. PCT/KR2021/010448
§ 371(c)(1), (2) Date Feb. 6, 2023,
PCT Pub. No. WO2022/031130, PCT Pub. Date Feb. 10, 2022.
Claims priority of application No. 10-2020-0098773 (KR), filed on Aug. 6, 2020.
Prior Publication US 2023/0279042 A1, Sep. 7, 2023
Int. Cl. C07J 9/00 (2006.01)
CPC C07J 9/005 (2013.01) 8 Claims
 
1. An inotodiol ester derivative compound formed through an ester condensation reaction between a hydroxyl group of an inotodiol compound of Formula 1 below and a carboxyl group of a fatty acid, glucuronic acid, alkyl succinic anhydride, or phenolic acid, or a pharmaceutically acceptable salt thereof:

OG Complex Work Unit Chemistry